Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
676,935
-
Share change
-
+523,668
-
Total reported value
-
$3,563,000
-
Price per share
-
$5.26
-
Number of holders
-
17
-
Value change
-
+$2,722,188
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q4 2015
As of 31 Dec 2015,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
676,935 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, First Eagle Investment Management, LLC, A.R.T. Advisors, LLC, Spark Investment Management LLC, MENTA CAPITAL LLC, MORGAN STANLEY, NEXTHERA CAPITAL LP, CREDIT SUISSE AG/, ELLINGTON MANAGEMENT GROUP LLC, and Smith Asset Management Group LP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.